Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 2/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | JAK2 | O60674 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.32 |
| ▸ | RELA | Q04206 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28018299 | 0.75 | KDM1A (0.38) | KDM1AMAOBMEN1JAK2LMNA | |
| SCHEMBL28413151 | 0.75 | KDM1A (0.42) | KDM1AMAOBMEN1JAK2LMNA | |
| SCHEMBL30874319 | 0.75 | KDM1A (0.38) | KDM1AMAOBMEN1JAK2LMNA | |
| SCHEMBL27425145 | 0.75 | KDM1A (0.38) | KDM1AMAOBMEN1JAK2LMNA | |
| SCHEMBL29962540 | 0.75 | KDM1A (0.42) | KDM1AMAOBMEN1JAK2LMNA | |
| SCHEMBL7088421 | 0.72 | KDM1A (0.36) | KDM1AMAOBMEN1JAK2LMNA | |
| SCHEMBL8986269 | 0.72 | KDM1A (0.36) | KDM1AMAOBMEN1JAK2LMNA | |
| SCHEMBL8830381 | 0.71 | KDM1A (0.35) | KDM1AMAOBMEN1JAK2LMNA | |
| SCHEMBL28036686 | 0.71 | KDM1A (0.35) | KDM1AMAOBMEN1JAK2LMNA | |
| SCHEMBL27945379 | 0.71 | KDM1A (0.35) | KDM1AMAOBMEN1JAK2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5184323-A | Optical coupling of intersecting beams of electromagnetic radiation; potential gradients; molecular dipoles containing electron donor linked to electron acceptor through pi bonding system | EASTMAN KODAK COMPANY (US) | 1993-02-02 | — | — | US | claimed |
| US-5115336-A | PHOTOREFRACTIVE SYSTEM AND PROCESS FOR ITS USE | EASTMAN KODAK COMPANY (US) | 1992-05-19 | — | — | US | claimed |
| EP-0446154-A2 | Photorefractive device | EASTMAN KODAK COMPANY (US) | 1991-09-11 | — | — | EP | claimed |
| EP-0446153-A2 | Photorefractive system and process for its use | EASTMAN KODAK COMPANY (US) | 1991-09-11 | — | — | EP | claimed |
| US-4999809-A | Electrical biasing means for potential gradients, electromagnetic beams for images, multilayer elements | EASTMAN KODAK COMPANY (US) | 1991-03-12 | — | — | US | claimed |
| US-4019905-A | Method for forming fluorescent screen of color cathode ray tubes using filter layer | HITACHI, LTD. (JA) | 1977-04-26 | — | — | US | claimed |
| CN-115298040-B | Cylindrical printing plate and method for producing printed matter | 东丽株式会社 | 2024-08-02 | — | — | CN | disclosed |
| CN-117581157-A | Waterless lithographic printing plate precursor, method for producing waterless lithographic printing plate, method for sorting waterless lithographic printing plate, and method for producing printed matter | 东丽株式会社 | 2024-02-20 | — | — | CN | disclosed |
| US-9180212-B2 | β-amyloid plaque imaging agents | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-11-10 | — | — | US | disclosed |
| US-20130315826-A1 | Beta-Amyloid Plaque Imaging Agents | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-11-28 | — | — | US | disclosed |
| US-7534468-B2 | Process for obtaining spatially-organised nanostructures on thin films | SCRIBA NANOTECHNOLOGIE S.R.L. (IT) | 2009-05-19 | — | — | US | disclosed |
| US-20060019439-A1 | Process for obtaining spatially-organised nanostructures on thin films | SCRIBA NANOTECNOLOGIE S.R.L. (IT) | 2006-01-26 | — | — | US | disclosed |
| US-20050194882-A1 | Color cathode ray tube with optical filter system | KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) | 2005-09-08 | — | — | US | disclosed |
| US-20010050527-A1 | Color picture screen with color filter | KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) | 2001-12-13 | — | — | US | disclosed |
| CN-1322001-A | Color picture fluorescent screen having color filter | KONINKL PHILIPS ELECTRONICS NV (NL) | 2001-11-14 | — | — | CN | disclosed |
| US-5184323-A | Optical coupling of intersecting beams of electromagnetic radiation; potential gradients; molecular dipoles containing electron donor linked to electron acceptor through pi bonding system | EASTMAN KODAK COMPANY (US) | 1993-02-02 | — | — | US | disclosed |
| EP-0446154-A2 | Photorefractive device | EASTMAN KODAK COMPANY (US) | 1991-09-11 | — | — | EP | disclosed |
| EP-0446153-A2 | Photorefractive system and process for its use | EASTMAN KODAK COMPANY (US) | 1991-09-11 | — | — | EP | disclosed |
| US-4999809-A | Electrical biasing means for potential gradients, electromagnetic beams for images, multilayer elements | EASTMAN KODAK COMPANY (US) | 1991-03-12 | — | — | US | disclosed |
| US-4019905-A | Method for forming fluorescent screen of color cathode ray tubes using filter layer | HITACHI, LTD. (JA) | 1977-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130315826-A1 | Beta-Amyloid Plaque Imaging Agents | APP, SLC6A2, BACE1 | KDM1A 4801/4885MAOB 170/4885MEN1 996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.